OR WAIT null SECS
The trends shaping the growth of the biologics outsourcing industry demand attention.
The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines.
In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.
May 15, 2023
The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.
Can CDMOs apply lessons learned from the COVID-19 pandemic to improve sterile processing?
May 01, 2023
Preclinical studies specifically benefit from the “smart” drug development trend through deeper data access and analysis.
April 14, 2023
Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.
April 03, 2023
March 29, 2023
Anil Kane, executive director, Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, discusses the growing role of CDMOs in the biopharma industry
March 27, 2023
Stephen Houldsworth, VP and Head of Platform Management & Marketing at CordenPharma, dives into ongoing trends in the outsourcing space.
March 22, 2023
In addition to a new interim president, the company is opening new microbial capacity at its San Antonio facility and has plans to construct a commercial-scale facility in Manhattan, Kan.
March 01, 2023